- Home
- GIB vs PEN Comparison
GIB vs PEN Comparison
Compare GIB & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GIB | PEN |
|---|---|---|
| Founded | 1976 | 2004 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.0B | 14.0B |
| IPO Year | 1999 | 2015 |
Fundamental Metrics
Financial Performance| Metric | GIB | PEN |
|---|---|---|
| Price | $73.26 | $343.65 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 17 |
| Target Price | $117.00 | ★ $357.33 |
| AVG Volume (30 Days) | 552.0K | ★ 791.3K |
| Earning Date | 01-01-0001 | 05-26-2026 |
| Dividend Yield | ★ 0.63% | N/A |
| EPS Growth | N/A | ★ 1155.56 |
| EPS | N/A | ★ 4.52 |
| Revenue | N/A | ★ $1,403,665,000.00 |
| Revenue This Year | $8.33 | $13.92 |
| Revenue Next Year | $2.96 | $13.82 |
| P/E Ratio | ★ $13.59 | $75.65 |
| Revenue Growth | N/A | ★ 17.50 |
| 52 Week Low | $69.96 | $221.26 |
| 52 Week High | $110.07 | $362.41 |
Technical Indicators
Market Signals| Indicator | GIB | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 33.51 | 55.92 |
| Support Level | N/A | $337.63 |
| Resistance Level | $93.65 | $362.41 |
| Average True Range (ATR) | 2.29 | 2.18 |
| MACD | 0.00 | -1.00 |
| Stochastic Oscillator | 28.15 | 89.60 |
Price Performance
Historical ComparisonAbout GIB CGI Inc.
CGI is a Canada-based IT-services provider with an embedded position in North America and Europe. The company is one of the major IT suppliers to different levels of government around the world. It offers a broad portfolio of services such as consulting, systems integration, application maintenance, and business process services to governments and the private sector. With offices in over 40 countries, CGI follows a balanced global delivery model with most consultants in client proximity.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.